Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Allogeneic transplantation for chronic lymphocytic leukemiaLuca Laurenti, Michela Tarnani, Patrizia Chiusolo, et al.
Haematologica|August 5, 2005
Low-dose intravenous alemtuzumab therapy in pretreated patients affected by chronic lymphocytic leukemia. A single center experienceLuca Laurenti, Paola Piccioni, Michela Tarnani, et al.
Acta Haematologica|April 29, 2010
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipientsMariangela Palladino, Luca Laurenti, Patrizia Chiusolo, et al.
Leukemia Research|February 22, 2011
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluationLuca Laurenti, Laura De Padua, Remo Battendieri, et al.
Haematologica|October 13, 2004
Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovirLuca Laurenti, Paola Piccioni, Paola Cattani, et al.
Cancer Reports (Hoboken, N.J.)|March 12, 2025
Spleen Involvement at Diagnosis of Multiple Myeloma: A Case Report and Literature ReviewAlessia Fiorini, Maria Gabriela Chavez, Valentina Panichi, et al.
Clinical Transplantation|March 15, 2008
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapyLuca Laurenti, Michela Tarnani, Patrizia Chiusolo, et al.
Leukemia Research|July 4, 2006
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemiaLuca Laurenti, Paola Piccioni, Michela Tarnani, et al.
Leukemia Research|January 16, 2010
The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemiaMichela Tarnani, Luca Laurenti, Pablo G Longo, et al.
Haematologica|November 4, 2005
Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemiaLuca Laurenti, Aleksandar Petlickovski, Carlo Rumi, et al.
Pageof 3